MoneyWorks4Me

Zydus Lifesciences informs about press release

30 Aug 2022 Evaluate
Zydus Lifesciences has informed about Press Release dated August 30, 2022 titled 'Zydus announces Phase IV DREAM-CKD trial to generate Real World Evidence of Desidustat in patients with chronic kidney disease induced anemia'.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..